[Variation of expression level and activity of coagulation factor ⅩⅢ in acute myeloid leukemia patients].
作者信息
Shi D Y, Wang S J, Zhao Y Q, Fan L K, Wu W
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2018 Oct 14;39(10):859-861. doi: 10.3760/cma.j.issn.0253-2727.2018.10.014.
Abstract
摘要
相似文献
1
[Variation of expression level and activity of coagulation factor ⅩⅢ in acute myeloid leukemia patients].
Zhonghua Xue Ye Xue Za Zhi. 2018 Oct 14;39(10):859-861. doi: 10.3760/cma.j.issn.0253-2727.2018.10.014.
2
[Blood coagulation disorders in leukemia].
Wien Med Wochenschr. 1991;141(9-10):213-6.
3
CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia.
Jpn J Clin Oncol. 2010 Nov;40(11):1046-52. doi: 10.1093/jjco/hyq098. Epub 2010 Jun 17.
4
Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.
Tumour Biol. 2017 Apr;39(4):1010428317699123. doi: 10.1177/1010428317699123.
5
[ACUTE MYELOID LEUCOSIS WITH HYPERFIBRINOLYSIS. CLINICAL AND BLOOD COAGULATION STUDIES IN A CASE].
Prog Med (Napoli). 1963 Apr 15;19:218-24.
6
Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment.
Leuk Lymphoma. 1999 Dec;36(1-2):77-84. doi: 10.3109/10428199909145951.
7
Effect of leukapheresis on blood coagulation in patients with hyperleukocytic acute myeloid leukemia.
Transfus Apher Sci. 2017 Apr;56(2):214-219. doi: 10.1016/j.transci.2016.12.001. Epub 2016 Dec 29.
8
Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.
Clin Appl Thromb Hemost. 2007 Jul;13(3):292-8. doi: 10.1177/1076029607302435.
9
Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Haematologica. 2018 Sep;103(9):1462-1471. doi: 10.3324/haematol.2017.186734. Epub 2018 May 17.
10
Biologico-clinical significance of DNMT3A variants expression in acute myeloid leukemia.
Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):270-277. doi: 10.1016/j.bbrc.2017.10.041. Epub 2017 Oct 9.
本文引用的文献
1
Newly-Recognized Roles of Factor XIII in Thrombosis.
Semin Thromb Hemost. 2016 Jun;42(4):445-54. doi: 10.1055/s-0036-1571343. Epub 2016 Apr 7.
2
Factor XIII: Structure and Function.
Semin Thromb Hemost. 2016 Jun;42(4):422-8. doi: 10.1055/s-0036-1571341. Epub 2016 Mar 28.
3
Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.
J Biol Chem. 2014 Mar 7;289(10):6526-6534. doi: 10.1074/jbc.M113.517904. Epub 2014 Jan 17.
4
New developments in the area of factor XIII.
J Thromb Haemost. 2013 Feb;11(2):234-44. doi: 10.1111/jth.12074.
5
Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia.
Cytometry B Clin Cytom. 2012 Jul;82(4):209-16. doi: 10.1002/cyto.b.21019. Epub 2012 Apr 26.
6
Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.
Physiol Rev. 2011 Jul;91(3):931-72. doi: 10.1152/physrev.00016.2010.
7
Factor XIII: novel structural and functional aspects.
J Thromb Haemost. 2011 Jan;9(1):9-20. doi: 10.1111/j.1538-7836.2010.04070.x.
8
Analyzing real-time PCR data by the comparative C(T) method.
Nat Protoc. 2008;3(6):1101-8. doi: 10.1038/nprot.2008.73.
9
Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A.
Thromb Haemost. 2006 Aug;96(2):176-82.
10
Coagulation factor XIII-A. A flow cytometric intracellular marker in the classification of acute myeloid leukemias.
Thromb Haemost. 2005 Aug;94(2):454-9. doi: 10.1160/TH05-03-0206.
Zotero 插件